HCW Biologics HCWB
NASDAQ HCWB
$1.71 -0.04 (-2.29%)
At close: Sep 30, 2026 · 4:00 PM EDT

HCW Biologics (HCWB) Non-Current Debt (2023 - 2025)

Updated

HCW Biologics' Non-Current Debt was -$32,847 in Q4 2025, compared with -$31,010 a year earlier.

Analysis

HCW Biologics (HCWB) Non-Current Debt (2023 - 2025) Analysis & Trends

For FY2025, Non-Current Debt at HCW Biologics came in at -$127,623.

  • In earlier years, Non-Current Debt was -$119,398 in FY2024 and -$38,273 in FY2023.
  • The Q4 2025 figure marks the lowest quarterly Non-Current Debt in data going back to Q3 2023.
  • Per Business Quant data, HCWB's Non-Current Debt in the three quarters before Q4 2025 was -$31,391 (Q3 2025), -$30,925 (Q2 2025) and -$32,460 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 37.34 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 62.48 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -108.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 23.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 HCW Biologics 2.27 Mn -3.96 Mn -93,887.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -32,847.00
Sep 30, 2025 -31,391.00
Jun 30, 2025 -30,925.00
Mar 31, 2025 -32,460.00
Dec 31, 2024 -31,010.00
Sep 30, 2024 -29,559.00
Jun 30, 2024 -29,123.00
Mar 31, 2024 -29,706.00
Dec 31, 2023 -29,292.00
Sep 30, 2023 -8,981.00
API Access

HCW Biologics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=HCWB&period=max&api_key=YOUR_API_KEY